Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Capital Employed (2024 - 2025)

Historic Return on Capital Employed for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to 0.26%.

  • CG Oncology's Return on Capital Employed fell 900.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.25% for FY2024, which is N/A changed from last year.
  • CG Oncology's Return on Capital Employed amounted to 0.26% in Q3 2025, which was down 900.0% from 0.23% recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Return on Capital Employed peaked at 0.15% during Q2 2024, and registered a low of 0.26% during Q3 2025.